Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Annovis Bio, Inc. (ANVS) had Normalized Pre-Tax Income of $-9.46M for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-9.46M |
|
-- |
|
-- |
|
$16.97M |
|
$-16.97M |
|
$7.51M |
|
$-9.46M |
|
|
Normalized Pre-Tax Income |
$-9.46M |
$-9.46M |
|
$-9.46M |
|
$-9.46M |
|
$-9.46M |
|
$-16.97M |
|
$-16.97M |
|
42.63M |
|
42.63M |
|
$-0.22 |
|
$-0.22 |
|
| Balance Sheet Financials | |
$5.50M |
|
-- |
|
-- |
|
$5.50M |
|
$6.26M |
|
-- |
|
$12.47M |
|
$18.74M |
|
$-13.23M |
|
$-13.23M |
|
$-13.23M |
|
42.69M |
|
| Cash Flow Statement Financials | |
$-46.96M |
|
-- |
|
$30.25M |
|
$19.53M |
|
$2.82M |
|
$-16.71M |
|
$2.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-46.96M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
71.50% |
|
71.50% |
|
-171.92% |
|
71.50% |
|
$-0.31 |
|
$-1.10 |
|
$-1.10 |
|